Phantom Neuro develops minimally invasive implantable technologies designed to enable intuitive control of prosthetic and robotic limbs. The company’s platform focuses on interfacing with residual muscle tissue to capture motor intent signals in amputees. Its approach combines implantable hardware with external software systems to translate biological signals into precise control commands. Phantom Neuro positions its technology within assistive neurotechnology and rehabilitation contexts.

The technology uses small muscle implants that record electromyographic signals associated with intended movement. These signals are processed using AI-driven decoding algorithms to generate real-time control inputs for prosthetic or robotic devices. By interfacing at the muscle level rather than directly with the brain, the system aims to achieve high signal fidelity with reduced invasiveness. The platform emphasizes low latency, stability, and adaptability to individual users.

Phantom Neuro targets individuals with limb loss who require advanced, intuitive control of prosthetic devices. The system is intended to support clinical rehabilitation and long-term assistive use rather than consumer applications. Its positioning reflects broader efforts to bridge biological motor intent and machine control through minimally invasive, scalable neural and muscular interfaces.